Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Medicare GLP-1 coverage (BALANCE transitional model, July 2026)
Our peptides are pharmaceutical-grade and sourced through reputable compounding partners, and we monitor your response through regular check-ins and follow-up labs
Compound Information Recommended Dose: 1-4mg per day
PT-141 (Bremelanotide): Melanocortin Receptor Research Guide PT-141 (Bremelanotide) is a cyclic heptapeptide derived from Melanotan II, modified to remove MC1R activity and concentrate action at the central MC3R and MC4R receptors
Her background includes inpatient bedside nursing, outpatient infusion services, and serving as a Gynecologic Oncology Nurse Navigator
When Doctors Recommend Both Medications Together Healthcare providers typically suggest combining metformin and semaglutide for patients with type 2 diabetes, prediabetes, or metabolic syndrome who need both glucose control and weight reduction
US$ 22.51
US$ 26.63
US$ 29.71
US$ 28.19
US$ 23.55
